Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Cited by (1,048)

Items 1,001–1,048 of 1,048

1. Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain
   Adriana Carino, Federica Moraca, Bianca Fiorillo, Silvia Marchianò, Valentina Sepe, Michele Biagioli, Claudia Finamore, Silvia Bozza, Daniela Francisci, Eleonora Distrutti et al. · 2020 · Frontiers in Chemistry
2. Unprecedented environmental and energy impacts and challenges of COVID-19 pandemic
   Azhar Siddique, Asif Shahzad, Jenny Lawler, Khaled A. Mahmoud, Dae Sung Lee, Nisar Ali, Muhammad Bilal, Kashif Rasool · 2020 · Environmental Research
3. COVID-19: A challenge for electrochemical biosensors
   Jiří Kudr, Petr Michálek, Lada Ilieva, Vojtěch Adam, Ondřej Zítka · 2021 · TrAC Trends in Analytical Chemistry
4. Angiotensin‐converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS‐CoV‐2: A double‐edged sword?
   Yan, Tiantian, Xiao, Rong, Lin, Guoan · 2020 · The FASEB Journal
5. Recombinant vaccines for COVID-19
   Yadav, Tushar, Srivastava, Nishant, Mishra, Gourav, Dhama, Kuldeep, Kumar, Swatantra, Puri, Bipin, Saxena, Shailendra K · 2020 · Human Vaccines & Immunotherapeutics
6. Landscape analysis of escape variants identifies SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
   Liu, Zhuoming, VanBlargan, Laura A., Bloyet, Louis-Marie, Rothlauf, Paul W., Chen, Rita E., Stumpf, Spencer, Zhao, Haiyan, Errico, John M., Theel, Elitza S., Liebeskind, Mariel J. et al. · 2020
7. SARS-CoV-2 infection and viral fusogens cause neuronal and glial fusion that compromises neuronal activity
   Martínez-Mármol, Ramón, Giordano-Santini, Rosina, Kaulich, Eva, Cho, Ann-Na, Przybyla, Magdalena, Riyadh, Md Asrafuzzaman, Robinson, Emilija, Chew, Keng Yih, Amor, Rumelo, Meunier, Frédéric A. et al. · 2023 · Science Advances
8. A single mRNA immunization boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
   Stamatatos, Leonidas, Czartoski, Julie, Wan, Yu-Hsin, Homad, Leah J., Rubin, Vanessa, Glantz, Hayley, Neradilek, Moni, Seydoux, Emilie, Jennewein, Madeleine F., MacCamy, Anna J. et al. · 2021
9. Cross-reactive serum and memory B cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection
   Song, Ge, He, Wan-ting, Callaghan, Sean, Anzanello, Fabio, Huang, Deli, Ricketts, James, Torres, Jonathan L., Beutler, Nathan, Peng, Linghang, Vargas, Sirena et al. · 2020
10. Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies
    Dufloo, Jérémy, Grzelak, Ludivine, Staropoli, Isabelle, Madec, Yoann, Tondeur, Laura, Anna, François, Pelleau, Stéphane, Wiedemann, Aurélie, Planchais, Cyril, Buchrieser, Julian et al. · 2021 · Cell Reports Medicine
11. A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability
    Voigt, Emily A., Gerhardt, Alana, Hanson, Derek, Jennewein, Madeleine F., Battisti, Peter, Reed, Sierra, Singh, Jasneet, Mohamath, Raodoh, Bakken, Julie, Beaver, Samuel et al. · 2022 · npj Vaccines
12. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury
    Sarzani, Riccardo, Giulietti, Federico, Di Pentima, Chiara, Giordano, Piero, Spannella, Francesco · 2020 · American Journal of Physiology-Lung Cellular and Molecular Physiology
13. Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models
    Kalnin, Kirill V., Plitnik, Timothy, Kishko, Michael, Zhang, Jinrong, Zhang, Donghui, Beauvais, Adrien, Anosova, Natalie G., Tibbitts, Tim, DiNapoli, Josh, Ulinski, Gregory et al. · 2021 · npj Vaccines
14. The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19
    Shah, Harsh, Khan, Md Shahjalal Hossain, Dhurandhar, Nikhil V., Hegde, Vijay · 2021 · Acta Diabetologica
15. Tackling COVID-19 with neutralizing monoclonal antibodies
    Corti, Davide, Purcell, Lisa A., Snell, Gyorgy, Veesler, David · 2021 · Cell
16. Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
    Suryadevara, Naveenchandra, Shrihari, Swathi, Gilchuk, Pavlo, VanBlargan, Laura A., Binshtein, Elad, Zost, Seth J., Nargi, Rachel S., Sutton, Rachel E., Winkler, Emma S., Chen, Elaine C. et al. · 2021
17. Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID
    Clough, Erin, Inigo, Joseph, Chandra, Dhyan, Chaves, Lee, Reynolds, Jessica L., Aalinkeel, Ravikumar, Schwartz, Stanley A., Khmaladze, Alexander, Mahajan, Supriya D. · 2021 · Journal of Neuroimmune Pharmacology
18. Cryo-EM: the resolution revolution and drug discovery
    de Oliveira, Taiana Maia, van Beek, Lotte, Shilliday, Fiona, Debreczeni, Judit É., Phillips, Chris · 2021 · SLAS DISCOVERY
19. Algae-derived bioactive molecules for the potential treatment of SARS-CoV-2
    Alam, Md. Asraful, Parra-Saldivar, Roberto, Bilal, Muhammad, Afroze, Chowdhury Alfi, Ahmed, Md. Nasir, Iqbal, Hafiz M.N., Xu, Jingliang · 2021 · Molecules
20. Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktail
    Dong, Jinhui, Zost, Seth J., Greaney, Allison J., Starr, Tyler N., Dingens, Adam S., Chen, Elaine C., Chen, Rita E., Case, James Brett, Sutton, Rachel E., Gilchuk, Pavlo et al. · 2021
21. Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques
    He, Xuan, Chandrashekar, Abishek, Zahn, Roland, Wegmann, Frank, Yu, Jingyou, Mercado, Noe B., McMahan, Katherine, Martinot, Amanda J., Piedra-Mora, Cesar, Beecy, Sidney et al. · 2021 · Cell
22. Molecular mechanisms and epidemiology of COVID-19 from an allergist’s perspective
    Hosoki, Koa, Chakraborty, Abhijit, Sur, Sanjiv · 2020 · Journal of Allergy and Clinical Immunology
23. The N-terminal domain of spike glycoprotein mediates SARS-CoV-2 infection by associating with L-SIGN and DC-SIGN
    Soh, Wai Tuck, Liu, Yafei, Nakayama, Emi E., Ono, Chikako, Torii, Shiho, Nakagami, Hironori, Matsuura, Yoshiharu, Shioda, Tatsuo, Arase, Hisashi · 2020
24. Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B
    Liu, Jun, Budylowski, Patrick, Samson, Reuben, Griffin, Bryan D., Babuadze, Giorgi, Rathod, Bhavisha, Colwill, Karen, Abioye, Jumai A., Schwartz, Jordan A., Law, Ryan et al. · 2022 · Science Advances
25. Repurposing potential of FDA‐approved and investigational drugs for COVID‐19 targeting SARS‐CoV‐2 spike and main protease and validation by machine learning algorithm
    Verma, Akalesh Kumar, Aggarwal, Rohit · 2021 · Chemical Biology & Drug Design
26. Fragment-based computational design of antibodies targeting structured epitopes
    Aguilar Rangel, Mauricio, Bedwell, Alice, Costanzi, Elisa, Taylor, Ross J., Russo, Rosaria, Bernardes, Gonçalo J. L., Ricagno, Stefano, Frydman, Judith, Vendruscolo, Michele, Sormanni, Pietro · 2022 · Science Advances
27. COVID-19 and the digestive system: A comprehensive review
    Wang, Ming-Ke, Yue, Hai-Yan, Cai, Jin, Zhai, Yu-Jia, Peng, Jian-Hui, Hui, Ju-Fen, Hou, Deng-Yong, Li, Wei-Peng, Yang, Ji-Shun · 2021 · World Journal of Clinical Cases
28. Neuropsychological functioning in severe acute respiratory disorders caused by the coronavirus: implications for the current COVID-19 pandemic.
    Rabinovitz, Beth, Jaywant, Abhishek, Fridman, Chaya B. · 2020 · The Clinical Neuropsychologist
29. Nasal disinfection for the prevention and control of COVID-19: A scoping review on potential chemo-preventive agents
    Cegolon, L., Javanbakht, M., Mastrangelo, G. · 2020 · International Journal of Hygiene and Environmental Health
30. Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman Primates
    Corbett, Kizzmekia S., Nason, Martha C., Flach, Britta, Gagne, Matthew, O’ Connell, Sarah, Johnston, Timothy S., Shah, Shruti N., Edara, Venkata Viswanadh, Floyd, Katharine, Lai, Lilin et al. · 2021
31. Anchor-Locker Binding Mechanism of the Coronavirus Spike Protein to Human ACE2: Insights from Computational Analysis
    Cong, Yalong, Feng, Yinghui, Ni, Hui, Zhi, Fengdong, Miao, Yulu, Fang, Bohuan, Zhang, Lujia, Zhang, John Z. H. · 2021 · Journal of Chemical Information and Modeling
32. Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies
    Muecksch, Frauke, Weisblum, Yiska, Barnes, Christopher O., Schmidt, Fabian, Schaefer-Babajew, Dennis, Lorenzi, Julio C C, Flyak, Andrew I, DeLaitsch, Andrew T, Huey-Tubman, Kathryn E, Hou, Shurong et al. · 2021
33. Are Older People Really More Susceptible to SARS-CoV-2?
    Zhang, Shuo, Yang, Zhen, Li, Zhuo-Ning, Chen, Zhen-Lin, Yue, Shi-Jun, Fu, Rui-Jia, Xu, Ding-Qiao, Zhang, Sai, Tang, Yu-Ping · 2022 · Aging and disease
34. Different Neutralization Sensitivity of SARS-CoV-2 Cell-to-Cell and Cell-Free Modes of Infection to Convalescent Sera
    Kruglova, Natalia, Siniavin, Andrei, Gushchin, Vladimir, Mazurov, Dmitriy · 2021 · Viruses
35. COVID-19 research risks ignoring important host genes due to pre-established research patterns
    Stoeger, Thomas, Nunes Amaral, Luís A · 2020 · eLife
36. The receptor binding domain of SARS-CoV-2 spike is the key target of neutralizing antibody in human polyclonal sera
    Steffen, Tara L., Stone, E. Taylor, Hassert, Mariah, Geerling, Elizabeth, Grimberg, Brian T., Espino, Ana M., Pantoja, Petraleigh, Climent, Consuelo, Hoft, Daniel F., George, Sarah L. et al. · 2020
37. Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals
    Lederer, Katlyn, Parvathaneni, Kalpana, Painter, Mark M., Bettini, Emily, Agarwal, Divyansh, Lundgreen, Kendall A., Weirick, Madison, Goel, Rishi R., Xu, Xiaoming, Drapeau, Elizabeth M. et al. · 2021
38. Race to the Bottom: Competition and Quality in Science
    Hill, Ryan, Stein, Carolyn · 2025 · The Quarterly Journal of Economics
39. Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike
    Graham, Carl, Seow, Jeffrey, Huettner, Isabella, Khan, Hataf, Kouphou, Neophytos, Acors, Sam, Winstone, Helena, Pickering, Suzanne, Galao, Rui Pedro, Lista, Maria Jose et al. · 2021
40. Variant-specific vaccination induces systems immune responses and potent in vivo protection against SARS-CoV-2
    Peng, Lei, Renauer, Paul A., Ökten, Arya, Fang, Zhenhao, Park, Jonathan J., Zhou, Xiaoyu, Lin, Qianqian, Dong, Matthew B., Filler, Renata, Xiong, Qiancheng et al. · 2022 · Cell Reports Medicine
41. Anti-inflammatory effects of GLP-1 in patients with COVID-19
    Sazgarnejad, Saharnaz, Yazdanpanah, Niloufar, Rezaei, Nima · 2022 · Expert Review of Anti-infective Therapy
42. Counter-regulatory renin-angiotensin system in hypertension: review and update in the era of COVID-19 pandemic
    Chen, Hongyin, Peng, Jiangyun, Wang, Tengyao, Wen, Jielu, Chen, Sifan, Huang, Yu, Zhang, Yang · 2023 · Biochemical Pharmacology
43. Isolation of cross-reactive monoclonal antibodies against divergent human coronaviruses that delineate a conserved and vulnerable site on the spike protein
    Wang, Chunyan, van Haperen, Rien, Gutiérrez-Álvarez, Javier, Li, Wentao, Okba, Nisreen M.A., Albulescu, Irina, Widjaja, Ivy, van Dieren, Brenda, Fernandez-Delgado, Raul, Sola, Isabel et al. · 2020
44. Immunogenicity of novel mRNA COVID-19 vaccine MRT5500 in mice and non-human primates
    Kalnin, Kirill V., Plitnik, Timothy, Kishko, Michael, Zhang, Jinrong, Zhang, Donghui, Beauvais, Adrien, Anosova, Natalie G., Tibbitts, Timothy, DiNapoli, Joshua M., Huang, Po-Wei D. et al. · 2020
45. Fighting COVID-19 with Artificial Intelligence
    Monteleone, Stefania, Kellici, Tahsin F., Southey, Michelle, Bodkin, Michael J., Heifetz, Alexander · 2022 · Methods in molecular biology
46. Artificial intelligence in the experimental determination and prediction of macromolecular structures
    Thorn, Andrea · 2022 · Current Opinion in Structural Biology
47. Exosomes in COVID‐19 infection: Focus on role in diagnosis, pathogenesis, immunity, and clinical trials
    Aljuhani, Alhanouf, Albalawi, Omniah, Albalawi, Rahaf, Alsalama, Reem, Alatawi, Safyah, Altemani, Reem, Abdel‐Maksoud, Mohamed S., Elsherbiny, Nehal · 2023 · Cell Biology International
48. Systemic profiling of immune responses in healthy adults vaccinated with an RBD-targeting COVID-19 mRNA vaccine
    Zhou, Chao, Sun, Mengxu, Huang, Xingyao, Liu, Pu, Ouyang, Zhangyi, Wu, Mei, Yuan, Lin, Chen, Jingjing, Shu, Wenjie, Cao, Tianshu et al. · 2025 · hLife